Overall rank by patents
#44,620
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 4 technology areas, active 2020–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
Arysta holds 5 US patents across 4 technology areas, rank #44,620 of 50,000 tracked assignees.
Arysta Lifescience Benelux SPRL has been granted 5 US utility patents between 2020 and 2023, placing Arysta Lifescience Benelux SPRL at rank #44,620 across all assignees tracked by PlainPatent. This portfolio spans 4 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, Arysta Lifescience Benelux SPRL is one of the more focused assignees in the PatentsView dataset. By volume, Arysta sits between ARTS (5 patents, rank #44,616) and Asahi Shipping Co., Ltd. (5 patents, rank #44,624) - the closest US assignees by grant volume. The composite Innovation Score of 24.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2023, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Arysta Lifescience Benelux SPRL's 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 4 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Arysta Lifescience Benelux SPRL against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ARTS
5 patents
ARUP VENTURES LIMITED
5 patents
ARVA INTELLIGENCE CORP.
5 patents
ARWALL, INC.
5 patents
ARYSTA LIFESCIENCE NORTH AMERICA, LLC
5 patents
ASAHI FIBER GLASS CO., LTD.
5 patents
ASAHI FR R&D CO., LTD.
5 patents
ASAHI SHIPPING CO., LTD.
5 patents
ARYSTA LIFESCIENCE BENELUX SPRL
5 patents
What this shows Arysta holds 5 patents at rank #44,620, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #44,620 in granted patent volume.
Other assignees with the most granted patents in Arysta's primary technology class.
Arysta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 20.0% |
| 2021 | 2 | 40.0% |
| 2022 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
Top 4 of 4 technology areas
Overall rank by patents
#44,620
Across all tracked assignees
24.5 out of 100
How to use this portfolio
Arysta's 5 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.